跳至主要内容
临床试验/CTRI/2021/12/038771
CTRI/2021/12/038771尚未招募未知

evels of Ischemia Modified Albumin in Polycystic Ovarian Syndrome Patients

AIIMS Nagpur0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
未知
状态
尚未招募
发起方
AIIMS Nagpur

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

入选标准

  • Patients diagnosed with PCOS (Rortterdam criteria ) will be recruited in the study. Controls will include 40 healthy age matched women without any clinical features of PCOS, as defined in Rotterdam criteria.

排除标准

  • Exclusion criteria will include patients with hyperprolactinemia; thyroid dysfunction; adrenal dysfunction; hypertension; pregnancy; any history of cancer; neurological disorders like Parkinsonâ??s disease, alzheimerâ??s disease, respiratory diseases like asthma; history of taking hormonal treatment/antiepileptic drugs/ hypertensive medications/ insulin sensitizing drugs/ statins/ aspirin in last 3 months; autoimmune disease; type 1/2 diabetes mellitus; acute inflammatory conditions; acute pancreatitis; acute cholecystitis; cardiac ischemia; kidney failure and current smoker

研究者

发起方
AIIMS Nagpur

相似试验

evels of Ischemia Modified Albumin in Polycystic... | 临床试验